Skip to Content
Assistant Professor of Ophthalmology and Visual Sciences
Primary Office: 11196 H PFPIowa City, IA 52242
Primary Office Phone: 319-356-8350
Email: email@example.comWeb: The Stephen A. Wynn Institute for Vision Research
BA, Chemistry, Williams CollegeMD, University of Washington School of Medicine
Internship, Internal Medicine, University of WashingtonResidency, Ophthalmology, University of WashingtonFellowship, Medical Retina, Moorfields Eye HospitalFellowship, Vitreoretinal Surgery, Doheney Eye Institute/USC
ABO Certification American Board of OphthalmologyNBME Diplomate National Board of Medical Examiners
Dr. Sohn engages in translational and clinical research related to retinal diseases, especially
(1) age-related macular degeneration: from stem cell therapies to clinical trials to basic mechanisms of the pathophysiology especially related to genotype
and (2) diabetic retinopathy: tissue and image-based analysis in mice and humans with focus on pathophysiology and treatment
inherited macular dystrophies and retinal degenerations: gene and stem cell therapies in pigs and humans (two clinical trials underway with more upcoming) as well as phenotype-genotype correlations.
Carver Family Center for Macular DegenerationStephen A. Wynn Institute for Vision Research
Comparison of drusen and modifying genes in autosomal dominant radial drusen and age-related macular degeneration (Epub ahead of Print).
2014 July 30.
Structural and biochemical analyses of choroidal thickness in human donor eyes.
Invest Ophthalmol Vis Sci.
2014 March 6. 55(3):1352-1360.
Loss of CD34 expression in aging human choriocapillaris endothelial cells.
2014 January 21. 9(1):e86538.
Decreased macular thickness in non-proliferative macular telangiectasia type 2 with oral carbonic anhydrase inhibitors.
The membrane attack complex in aging human choriocapillaris: Relationship to macular degeneration and choroidal thinning.
American Journal of Pathology.
Combination therapy for neovascular age-related macular degeneration refractory to anti-vascular endothelial growth factor agents.
2013 October. 120(10):2029-2034.
Aflibercept therapy for exudative age-related macular degeneration resistant to bevacizumab and ranibizumab.
Am J Ophthalmol.
2013 July. 156(1):15-22.
Reproducibility of diabetic macular edema estimates from SD-OCT is affected by the choice of image analysis algorithm.
Invest Ophthalmol Vis Sci.
2013 June 19. 54(6):4184-4188.
Angiofibrotic response to vascular endothelial growth factor inhibition in diabetic retinal detachment. Report No. 1.
2012 September 1. 130(9):1127-1134.
Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for non-necrotizing, noninfectious anterior scleritis.
2011 October. 118(10):1932-1937.
Date Last Modified: 11/11/2014 -
Copyright © 2011 The University of Iowa. All Rights Reserved.